Latest news with #RanjanPai
Mint
6 days ago
- Health
- Mint
India has the potential to be a global lab for scalable longevity solutions: Accel's Prashanth Prakash
Bengaluru-based wellness startup Biopeak had raised $3.5 million recently in a funding round led by Prashanth Prakash, founding partner of Accel Partners, that also saw participation from Manipal Group's Ranjan Pai through his investment vehicle Claypond Capital and Zerodha's Nikhil Kamath and Nithin Kamath. In this exclusive interview, Prakash talks about longevity as a concept and its importance in future. Excerpts: Hello Prashanth, what was the thought process behind this investment decision? The timing of this investment is deeply intentional. We are at a unique intersection in human health where diagnostics, artificial intelligence, and longevity science are converging with extraordinary speed. Biopeak is building an integrated, precision health system grounded in global science but tailored to the unique biological, environmental, and lifestyle factors of the Indian population. This is not just a business bet—it's a belief that India will lead the world in next-generation healthcare. The thought process was simple: medicine is shifting from reactive to predictive and preventive, and Biopeak is among the few platforms architecting that future in a scalable, scientifically grounded way. It will enable us to plot with unprecedented detail personalised health trajectories for a specific individual using multi-dimensional data collection, integration, and prediction. The focus on deeply personalised healthcare is going to be huge in the future. Right? The transition from universal averages to personalised insights will represent a revolution in how we detect, predict, prevent adverse events and build resilience reserves. This new model of Biology and AI-led medicine is an exciting paradigm for the future of healthcare in our country that investors are excited to back. What's your definition of longevity? Longevity, for us, is not merely about extending the lifespan but expanding the healthspan. Ensuring more years that are healthy, vital, and productive is more crucial. In the Indian context, this requires a unique balance: respect for traditional knowledge systems, alignment with evolving regulatory frameworks, and deep reliance on evidence-based science. We're combining cutting-edge diagnostics—from microbiome and metabolomics to imaging and functional genomics—with culturally compatible interventions and a powerful AI layer. Longevity for us in India means democratising access to health optimisation—life partnerships between human intelligence and machine precision, rooted in science, ethics, and scale. In ancient civilizations including India, people were said to have lived for a much longer span of time. How do you relate that to the work Biopeak is doing and the results it is hoping to achieve? While environmental and societal contexts have changed drastically, ancient systems often emphasised internal balance, rhythm with nature, and preventative health —all are core principles in today's longevity science. At Biopeak, we're not romanticising the past—we're modelling it. Using symbolic and generative AI frameworks, we're integrating timeless health principles with modern biological data to predict individual responses to pharmaceuticals, nutraceuticals, and lifestyle interventions. It's not about replicating ancient lifespans—it's about reclaiming biological potential by harmonising past wisdom with today's precision tools. Do you think longevity as a concept can be realistically spread to all sections of society? Or will it remain only an aspiration of the well-heeled? Longevity must not become a luxury. With AI at the core of Biopeak's platform, we can rapidly model and scale health solutions based on outcomes from higher-touch cases to broader population needs. What starts with the few can be democratised for the many through intelligent design, efficient diagnostics, and continuous learning from diverse cohorts. India has the potential to be a global lab for scalable longevity solutions—not by diluting science but by deploying it with cultural and economic sensitivity. Through our own longitudinal data leveraging interdisciplinary collaboration (Longevity India, an initiative of the Indian Institute of Science), we aim to identify markers of organ system malfunction before pathology sets in so that we can implement a health management program which will extend healthspan and improve the quality of life for the ageing population across all sections of society. At the core of Biopeak's offering, I believe, is a diagnostic system that includes tests like organic acid profiling, microbiome mapping, salivary cortisol rhythms, and whole-exome functional genomics. These are paired with imaging tools such as MRI, CT, and ECHO, as well as tissue-level screenings that examine markers like mineral levels, toxin load, and oxidative stress. Does this make Biopeak a unique company in the world? Yes, Biopeak is unique both in its scientific architecture and its population focus. It combines multiple high-resolution diagnostic modalities—molecular, functional, and structural—into a unified health intelligence platform. Each individual is paired with a biologist and clinician, and guided through a dynamic health roadmap. What further sets it apart is its South Asia-centric design, which considers the genetic, dietary, cultural, and environmental nuances of this region. Supported by research from institutions like IISc and informed by global best practices, Biopeak is not just another health company—it's a systems-level rethink of what human health can be in the 21st century. What's Medicine 4.0? What does it look to solve? What are its basic principles? Medicine 4.0 is the natural evolution of healthcare in the age of AI and high-resolution biology. It's defined by its longitudinal view of health, multisystem diagnostics, real-time feedback loops, and personalised intervention frameworks. It's not about treating symptoms—it's about continuously adapting to the evolving biology of the individual. This approach integrates international technologies, leverages big data with small, precise insights, and focuses on outcomes over time rather than episodic care. In short, it's predictive, participatory, personalised, and preventive. What do you think are the key pillars of the Medicine 4.0 framework as far as BioPeak is concerned? Biopeak leverages data from modern genomics, metabolomics, lipidomics, and metagenomics analytics to provide a molecular view of an individual's unique biology. This integration identifies systemic equilibrium for identifying subtle imbalances and hidden dysfunctions long before symptoms arise. From DXA scans for bone density to functional MRIs and real-time metabolic imaging, Biopeak employs cutting-edge tools that visualise internal systems and structural health markers. Using a hybrid AI approach, combining symbolic AI (for precise, rule-based interpretations) and generative AI (for pattern recognition and predictive modelling), Biopeak can detect complex biological interrelations and generate personalised health insights. What do you think are the limitations of the current health systems worldwide and in India? Globally and in India, health systems remain largely reactive, fragmented, and oriented around acute interventions rather than long-term prevention. There's a heavy focus on managing disease rather than predicting and reversing the conditions that lead to it. What's missing is a systems view—an integration of diagnostics, therapeutics, and lifestyle within a cohesive, continuously updating framework. People are treated as conditions, not as dynamic ecosystems. Long-term biological consequences of current choices are rarely factored into care. The foundation of Medicine 2.0 was built on population averages, with protocols and interventions developed based on data from extensive observational and interventional studies. While this approach helped standardise treatments, it does not account for individual variability. Each person's genetic framework, metabolism, lifestyle, and environment interactions are unique, making the n=1 (individual-first) model essential for true health optimisation. Biopeak is solving for precisely this: unifying the fragmented landscape into an intelligent, longitudinal system centred around the individual.
&w=3840&q=100)
Business Standard
23-07-2025
- Business
- Business Standard
Manipal Group's Shruti Pai buys ₹64 cr duplex in Bengaluru's Jayamahal Ext
Shruti R Pai, wife of Manipal Education & Medical Group Chairman Ranjan Pai, has purchased a luxury duplex at Savyasachi Sarayu in Bengaluru's Jayamahal Extension for ₹64 crore—about ₹64,457 per sq ft of carpet area—according to property registry data via Zapkey. Spanning the 13th and 14th floors, the 12,800 sq ft super-built-up (9,929 sq ft carpet) apartment includes four covered parking spaces and a dedicated lumber room. It signals a growing preference among ultra-high-net-worth buyers for premium apartment living over standalone bungalows. The deal was registered on June 11, 2025, and the seller is listed as Parag S Maniar of Savyasachi Projects, represented by H Vijayanath Hegde, the documents showed. Jayamahal Extension—a heritage enclave near Bangalore Palace and the central business district—has experienced limited but steep luxury activity. This ₹64 crore transaction sets a new pricing benchmark and underscores strong HNI demand for amenity-rich, gated communities. Industry sources point to a broader uptick in Bengaluru's ultra-luxury transactions. Recent high-value deals include a ₹54 crore penthouse in central Bengaluru and a ₹67.5 crore bungalow in Koramangala. Earlier this year, Nithin Kamath, co-founder of Zerodha, reportedly picked up a sprawling bungalow in the Koramangala 3rd Block area for over Rs 70 crore, while Binny Bansal, Flipkart's co-founder, invested in a high-value residential plot in residential plot in Sadashivanagar for over Rs 55 crore. In 2024, Ajit Isaac, chairman and managing director of Bengaluru-based Quess Corp, bought a 10,000 sq ft property worth ₹67.5 crore in the Koramangala area. In May, Paresh Raja, CEO of UK-based Market Financial Solutions, bought a luxury penthouse in MAIA Estates's upscale 27 Summit project for ₹54.38 crore, as per documents accessed by Zapkey.
Time of India
22-07-2025
- Business
- Time of India
Manipal Group's promoter family buys Rs 64 cr ultra-luxury apartment in Bengaluru's Jayamahal Extension
Shruti R Pai, wife of Manipal Education and Medical Group Chairman Ranjan Pai, has purchased a luxury residential apartment in Bengaluru 's upscale Jayamahal Extension for Rs 64 crore, according to property registration data sourced from Zapkey. The transaction was executed with Savyasachi Projects, represented by Parag S. Maniar and H. Vijayanath Hegde. The property is located in the exclusive Savyasachi Sarayu project, a luxury residential tower comprising limited high-end units. The apartment spans the 13th and 14th floors and has a super built-up area of 12,800 sq ft, with a carpet area of 9,929 sq ft. Explore courses from Top Institutes in Please select course: Select a Course Category Digital Marketing Cybersecurity healthcare Leadership Data Science MCA Public Policy Others Operations Management Management Design Thinking MBA Product Management Artificial Intelligence Healthcare Technology Data Analytics Data Science PGDM others CXO Finance Degree Project Management Skills you'll gain: Digital Marketing Strategies Customer Journey Mapping Paid Advertising Campaign Management Emerging Technologies in Digital Marketing Duration: 12 Weeks Indian School of Business Digital Marketing and Analytics Starts on May 14, 2024 Get Details Skills you'll gain: Digital Marketing Strategy Search Engine Optimization (SEO) & Content Marketing Social Media Marketing & Advertising Data Analytics & Measurement Duration: 24 Weeks Indian School of Business Professional Certificate Programme in Digital Marketing Starts on Jun 26, 2024 Get Details At Rs 64 crore, the deal works out to Rs 64,457 per sq ft on carpet area — a benchmark rate for residential transactions in this micro-market, signaling the rising appetite for ultra-luxury residences in Bengaluru's old-money neighbourhoods. The property also includes four covered car parks, a lumber room in the basement amongst other amenities, mentioned the sales deed document. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You might be interested Undo 'This purchase reflects a growing trend in Bangalore's high-value property market. Previously, the Rs 50 crore-plus segment was dominated by bungalows, but we are now observing a clear rise in luxury apartment transactions at this level. This segment will likely expand as more developers cater to the demand for premium, amenity-rich gated living,' said Sandeep Reddy Co-founder of Propstack. Jayamahal Extension, located near the Bangalore Palace and in close proximity to the CBD, has seen limited but significant high-value real estate deals in recent years, driven by demand from legacy families, HNIs, and industrialists. This transaction is part of a broader trend of wealthy promoters and business families investing in marquee residential properties in Bengaluru, which has recently seen a spurt in luxury real estate activity. Live Events Earlier this year, Nithin Kamath , co-founder of Zerodha , reportedly picked up a sprawling bungalow in the Koramangala 3rd Block area for over Rs 70 crore, while Binny Bansal, Flipkart's co-founder, invested in a high-value residential plot in Sadashivanagar for over Rs 55 crore. Another significant deal included the family of Infosys co-founder Kris Gopalakrishnan purchasing a luxury villa in Whitefield's Palm Meadows enclave for approximately Rs 35 crore. According to analysts, limited inventory in prime neighbourhoods such as Jayamahal, Sadashivanagar, and Richmond Town is driving a price surge for premium properties. 'These are not speculative buys — families are acquiring them for self-use, legacy, or as lifestyle investments. The lack of high-quality inventory is pushing per square foot rates to record highs,' said a senior executive at a luxury real estate advisory firm. Experts say that demand intensifies, industry insiders expect a continued rise in big-ticket residential sales in the Rs 40–Rs 75 crore band, driven by NRI investors, family offices, and promoter groups reshoring wealth back into Indian assets. According to the latest Knight Frank Wealth Report 2025, the number of UHNIs (net worth above $30 million) in India grew by 12.4% in 2024, outpacing the global average. Bangalore alone is home to over 250 UHNIs, a number expected to cross 320 by 2027. The same report highlights that India added 1,200 new millionaires every week in 2024, many of whom are technology entrepreneurs, second-generation business families, and global professionals returning to India.
Mint
22-07-2025
- Business
- Mint
Shruti Pai buys ₹64 crore luxury duplex in Bengaluru's Jayamahal Extension
Bengaluru: Shruti Pai, founder and director of Sagework Design, has bought a luxury duplex for ₹ 64 crore in a boutique condominium complex in Bengaluru in one of the most expensive residential deals in the city. The 12,800 square foot apartment is spread across two floors in a project named Savyasachi Sarayu in the Jayamahal Extension area. The property was sold at ₹ 64,457 per sq. ft on the carpet area, as per documents accessed by real estate platform Zapkey. The sale deed was signed in June. Before Sagework, Shruti Pai was creative director at Manipal Education & Health Group. She is married to Dr. Ranjan Pai, chairman of the Manipal Education and Medical Group. Mumbai, India's most valuable property market, and Gurugram have topped the charts for a record number of luxury deals so far, including many ₹ 100 crore transactions. However, Bengaluru, which has always been a more affordable city for housing, is catching up. 'This deal reflects a growing trend in Bengaluru's high-value property market. Previously, the ₹ 50 crore-plus segment was dominated by bungalows, but we are now observing a clear rise in luxury apartment transactions at this level. This segment will likely expand as more developers cater to the demand for premium, amenity-rich gated living,' said Sandeep Reddy, co-founder of Zapkey. Shruti Pai could not be reached immediately for comment. Dr Ranjan Pai didn't respond to Mint's queries. The sale of homes in the ₹ 40-60 crore category in Bengaluru has picked up in recent months, driven by non-resident Indians, family offices and wealthy locals looking for modern homes. Last year, Bengaluru-based Quess Corp chairman and managing director Ajit Isaac bought a 10,000 sq. ft property worth ₹ 67.5 crore in the prime Koramangala area, making it the most expensive residential transaction in the city. For the first time, Bengaluru's ₹ 10 crore and above luxury market crossed the ₹ 1,000 crore mark in annual sales in 2024-25, marking a new benchmark for the city's premium housing sector, according to an April report by India Sotheby's International Realty and CRE Matrix. The report highlighted strong interest in apartment sizes from 5,000 to 7,000 sq. ft, reflecting the growing appetite for spacious, high-end living.
Time of India
15-07-2025
- Business
- Time of India
Manipal Hospitals borrows Rs 5,300 crore from global banks to fund Sahyadri acquisition
Mumbai: Manipal Hospitals , part of Mangalore-based Manipal Education and Medical Group (MEMG), is borrowing nearly ₹5,300 crore from five foreign banks to fund its acquisition of Sahyadri Hospitals , four people familiar with the plans said. The banks comprising European lenders Deutsche Bank and Barclays , Japan's Mitsubishi UFG Financial Group (MUFG) and Sumitomo Mitsui Banking Corp (SMBC), and Singapore's DBS Bank have agreed to provide the debt funding for the acquisition, the people said. "The total deal size is around ₹5,900 crore, 90% of which is funded by debt raised from these foreign banks. The rest 10% has to be paid next fiscal year," one of the persons said. "The debt is being funded by bonds issued by Manipal, maturing in two years at a yield of around 9.5%." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 새로운 재테크 찾는다면 '코인재테크' 시작하세요 나우투자그룹 더 알아보기 Undo Last week, Temasek-backed Manipal Hospitals signed an agreement to acquire Pune-based Sahyadri Hospitals from Ontario Teachers' Pension Plan (OTPP). The acquisition will make Manipal the largest private sector hospital chain in India, giving it 11 new hospitals across Pune, Nashik, Ahilya Nagar and Karad. Its total network will increase to 49 hospitals with bed capacity of 12,000. "The banks will invest in these bonds through the foreign portfolio investment (FPI) route since the funds are raised to fund a foreign-owned company, and Reserve Bank of India (RBI) rules do not permit banks to lend onshore for mergers and acquisitions," said a second person aware of the details. Live Events Barclays and MUFG declined to comment, while spokespersons for Deutsche and SMBC did not reply to emails seeking comment. "As a matter of principle, DBS Bank does not comment on specific transactions," said a spokesperson for DBS. FPI entities floated by these banks, most likely based out of Singapore, will subscribe to these bonds. Manipal will redeem these bonds in the next two years from the proceeds of its planned initial public offering (IPO). Singapore's $339 billion Temasek , one of the world's largest sovereign funds, owns 59% of Manipal Hospitals with promoter Ranjan Pai & family owning 30% and private equity investor TPG holding a 11% stake. An IPO is planned for 2026. A Manipal spokesperson did not reply to ET's email seeking comment. Foreign banks usually fund M&A deals in India through their overseas arms to tide over regulations in the country. The banks usually hold these bond investments to maturity showing them in the investment book in India. All five banks mentioned above have agreed to fund this deal with covenants signed on Monday, the people cited above said.
